DANMAP

DANMAP
Name	DANMAP
Formation	1995
Type	Surveillance programme
Headquarters	Copenhagen
Location	Denmark
Fields	Antimicrobial resistance, Public health, Veterinary medicine

DANMAP DANMAP is a Danish national surveillance programme monitoring antimicrobial use and resistance in humans and animals. It links data from hospitals, clinics, laboratories, farms, slaughterhouses and retail food chains to inform policy, clinical practice and veterinary medicine. Reports are produced annually and influence regulatory decisions, clinical guidelines and international collaborations.

Overview

DANMAP coordinates surveillance across institutions such as the Statens Serum Institut, National Food Institute (DTU Food), Danish Veterinary and Food Administration, University of Copenhagen, Aarhus University and regional hospitals like Rigshospitalet and Aalborg University Hospital. The programme integrates datasets from reference laboratories including the European Centre for Disease Prevention and Control, the World Health Organization, the European Food Safety Authority, the Food and Agriculture Organization, and the European Medicines Agency. DANMAP outputs inform stakeholders such as the Danish Parliament, the Ministry of Health (Denmark), the Ministry of Environment and Food (Denmark), professional bodies like the Danish Medical Association, veterinary organisations including the Danish Veterinary Association, and international networks such as the Norwegian Institute of Public Health and the Swedish Public Health Agency.

History and Development

The programme was established after dialogues involving the Danish Veterinary and Food Administration, the Statens Serum Institut and academic partners like Technical University of Denmark and University of Copenhagen in the mid-1990s, motivated by rising concerns voiced by institutions such as the World Health Organization and research groups at Karolinska Institutet and London School of Hygiene & Tropical Medicine. Early contributors included researchers from Aarhus University Hospital and policy advisors linked to the European Commission and the Organisation for Economic Co-operation and Development. Subsequent milestones involved collaborations with surveillance systems such as the European Antimicrobial Resistance Surveillance Network and initiatives at the Robert Koch Institute. Key reports influenced legislation debated in the Folketing and informed actions coordinated with partners like the National Institute for Public Health and the Environment and the European Food Safety Authority.

Methods and Data Collection

DANMAP employs microbiological methods aligned with standards from institutions such as the Clinical and Laboratory Standards Institute and the European Committee on Antimicrobial Susceptibility Testing. Data sources include clinical microbiology laboratories at hospitals like Herlev Hospital, private laboratories, national prescription registries such as the Danish National Prescription Registry, veterinary prescription data from agencies like the Danish Medicines Agency, and production data from slaughterhouses that interact with companies in the Danish Crown supply chain. Sampling frames reference facilities such as the Statens Serum Institut reference laboratory, regional microbiology units, and sentinel sites coordinated with the European Centre for Disease Prevention and Control. Analytical approaches draw on epidemiological expertise from Imperial College London, genomic methods used at Wellcome Sanger Institute, and statistical techniques applied in publications from Harvard T.H. Chan School of Public Health and the Johns Hopkins Bloomberg School of Public Health.

Findings and Impact

Reports have detailed trends in resistance for pathogens including Staphylococcus aureus, Escherichia coli, Salmonella enterica, Campylobacter jejuni, Enterococcus faecalis and Klebsiella pneumoniae. Findings influenced interventions such as reductions in use of growth promoters in production systems analogous to policies in Netherlands, changes to prescribing practices promoted by the Danish Medical Association, and regulatory limits enacted by the Danish Veterinary and Food Administration. DANMAP outputs contributed evidence used by the European Medicines Agency and by the World Health Organization Global Action Plan on Antimicrobial Resistance; they informed academic work at institutions such as Oxford University and Columbia University. The programme’s data supported private sector changes among firms comparable to Arla Foods and regulatory inspections at ports and slaughterhouses coordinated with the Danish Veterinary and Food Administration.

Governance and Funding

Governance involves partnerships among public bodies including the Statens Serum Institut, the National Food Institute (DTU Food), the Danish Veterinary and Food Administration, and academic partners such as Aarhus University and the University of Copenhagen. Funding streams have included allocations from the Ministry of Health (Denmark), grants awarded by national research councils like the Danish Council for Independent Research, and European funding mechanisms under the European Commission framework programmes. Collaborative projects have received support from international donors and agencies such as the World Health Organization and the European Centre for Disease Prevention and Control, and have engaged stakeholders including professional societies like the Danish Pharmacists' Association and industry representatives.

Criticisms and Limitations

Critiques raised by academics at institutions including Technical University of Denmark, Karolinska Institutet, and University of Copenhagen have addressed sampling representativeness, comparability with surveillance systems such as the European Antimicrobial Resistance Surveillance Network, and challenges integrating genomic data similar to work at the Wellcome Sanger Institute. Other limitations cited by commentators associated with the European Centre for Disease Prevention and Control and the World Health Organization relate to timeliness of reporting, heterogeneity in laboratory methods across sites like Rigshospitalet and regional units, and difficulties linking antimicrobial consumption data from the Danish National Prescription Registry to resistance outcomes. Ongoing debates in forums including conferences at European Society of Clinical Microbiology and Infectious Diseases and policy discussions in the Danish Parliament continue to shape methodological refinements.

Category:Public health surveillance in Denmark